Albemarle Corporation in the news

Albemarle Corp. stock performed worse than competitors on Wednesday.

Albemarle manufactures specialty chemicals and is a top producer of lithium, mainly for electric vehicle batteries.

Albemarle Corp (ALB) shares fell 3.4% on October 7, 2026, to $102.75, deemed overvalued by 28.6% with a GF Score of 80, and notable insider selling activity.

Albemarle Corporation significantly reduced its debt by $1.3 billion in March 2026 and improved its financial flexibility through divestments and a lower net debt-to-EBITDA ratio.

Albemarle (ALB) outperformed the S&P 500 in its latest trading session but has underperformed over the past month; the company is set to release earnings on November 4, 2026, with analysts expecting substantial growth, despite a current Zacks Rank of #4 (Sell) and a valuation that suggests it is undervalued.

UBS adjusted its price target for Albemarle Corporation to $150 from $175 while maintaining a 'Buy' rating.

Albemarle Corporation will release its third quarter 2026 earnings on November 4, with a conference call scheduled for November 5.

Albemarle Corporation is approaching its Q3 earnings release on November 4, 2026, after strong Q2 results driven by pricing, while analyst price targets show a wide range.

Mizuho lowered Albemarle's stock price target to $130, citing pressure from Chinese exports and high interest rates, despite increased Q2 2026 revenue and an upcoming CEO transition.

Albemarle Corporation's 12-month price target was reduced to $173.29, still implying a 66% upside with a consensus "Buy" rating.

Albemarle's financial flexibility improved through cost-cutting and asset sales despite a stock drop, while lithium demand remains robust.

Albemarle Corp. shares are down 1.38% at USD 103.58 with a $12.39 billion market cap, yet investor buying interest is strong.

Albemarle Corporation will release its third quarter 2026 earnings on November 4, 2026, followed by a conference call on November 5, 2026.

Albemarle is scheduled to release its third-quarter 2026 earnings on November 4, 2026, followed by a conference call on November 5, 2026, at 8 a.m. EST.

Albemarle's stock received a lowered price target of $130 from Mizuho due to cautious market outlook, despite its strong GF Score™, and is considered overvalued.

Albemarle Corporation will report Q3 2026 earnings on November 4, 2026, with a conference call scheduled for November 5.

Albemarle is announcing its Q3 2026 earnings on November 4th, with a conference call on November 5th.

Albemarle Corporation will release its third quarter 2026 earnings on November 4, 2026, followed by a conference call on November 5, 2026.

Albemarle Corporation's stock has underperformed recently, leading to a Zacks Rank #4 (Sell) despite strong projected year-over-year earnings growth for the current quarter and fiscal year.

Albemarle Corp. stock underperformed its competitors on Wednesday.